Eloxatin

GPTKB entity

Statements (36)
Predicate Object
gptkbp:instanceOf gptkb:brand
gptkb:drug
gptkbp:activeIngredient gptkb:oxaliplatin
gptkbp:affiliatedWith platinum-based antineoplastic agents
gptkbp:approvedBy 2002
gptkbp:ATCCode L01XA03
gptkbp:CASNumber 61825-94-3
gptkbp:chemicalFormula C8H14N2O4Pt
gptkbp:contraindication hypersensitivity to platinum compounds
gptkbp:eliminationHalfLife 9-25 hours
gptkbp:excretion urine
gptkbp:FDAApproved approved
gptkbp:heldBy antineoplastic agent
https://www.w3.org/2000/01/rdf-schema#label Eloxatin
gptkbp:indication adjuvant treatment of stage III colon cancer
treatment of advanced colorectal cancer
gptkbp:KEGGID gptkb:D01841
gptkbp:legalStatus prescription only
gptkbp:manufacturer gptkb:Sanofi
gptkbp:mechanismOfAction platinum-based DNA crosslinker
gptkbp:MedlinePlusID a607045
gptkbp:metabolism non-enzymatic biotransformation
gptkbp:pregnancyCategory D (US)
gptkbp:PubChem_CID gptkb:CHEMBL1351
DB00526
6857598
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect nausea
vomiting
diarrhea
peripheral neuropathy
myelosuppression
gptkbp:UNII 04ZR38536J
gptkbp:usedFor colorectal cancer
gptkbp:bfsParent gptkb:oxaliplatin
gptkbp:bfsLayer 7